<p>Update on Prognostic Markers for HBV-Related HCC</p>

<p>Hepatitis B virus (HBV) infection remains a significant etiological factor for hepatocellular carcinoma (HCC) globally. In recent years, researchers have delved into prognostic biomarkers associated with HBV-related HCC with the aim of improving patient outcomes and treatment strategies. This review synthesizes the latest advancements in the field of prognostic biomarkers for HBV-related HCC, encompassing the discovery of novel biological markers, their clinical applications, and potential future research directions. By analyzing the most recent findings, this article aims to provide clinicians and researchers with up-to-date information regarding the assessment of prognosis in HBV-related HCC, thereby enhancing the understanding of disease management and therapeutic approaches.</p>